PolypDx uses a proprietary technology platform to detect adenomatous polyps. The test uses metabolite biomarkers to detect polyps before they become malignant.
“PolypDx can be integrated into the diagnostic process for colon cancer and lowers the overall costs incurred by a patient who would otherwise have to undergo a colonoscopy just to assess polyp presence,” said Frost & Sullivan Research Analyst Madhumitha Rangesa.
More articles on gastroenterology:
Dr. Nitesh Ratnakar elected West Virginia ACG governor
5 gastroenterologists leadership moves
5 statistics on gastroenterologist compensation, career satisfaction
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
